期刊文献+

伊曲康唑mPEG-PLA聚合物胶束的制备及理化性质 被引量:5

Preparation and physico-chemical properties of itraconazole polymeric micelles using mPEG-PLA as a drug carrier
下载PDF
导出
摘要 研究以聚乙二醇单甲醚-聚丙交脂嵌段共聚物(mPEG-PLA)作为载体,制备伊曲康唑聚合物胶束(ITZ-PM)。以开环聚合法合成mPEG-PLA,以溶剂挥发-薄膜分散法制备ITZ-PM溶液,并将其冷冻干燥。分别使用HPLC、动态光散射法(DLS)、原子力显微镜(AFM)和差示扫描量热法(DSC)等手段对载药量、包封率、粒径与分布和胶束形态等进行表征,采用透析法考察ITZ-PM的体外释放,并对释放机制进行探讨。结果显示ITZ-PM载药量为3.82%,包封率为99.4%,平均粒径为37.8 nm,pH为4.48;DSC确证药物已被包封在胶束中;AFM显示胶束呈类球形;ITZ-PM较市售制剂有一定缓释作用,释药行为较为符合Peppas-Sahlin方程。研究结果表明mPEG-PLA能有效提高伊曲康唑的溶解度。 A formulation of itraconazole polymeric micelles was prepared using mPEG-PLA as the drug carrier. mPEG-PLA was synthesized by ring opening and polymerization reaction. ITZ-PM was prepared by solvent evaporation-film dispersion method. The drug-loading and entrapment efficiency were characterized by I-IPLC. The physico:ehemical properties of ITZ-PM was characterized by dynamic light scattering ( DLS), atomic force microscopy (AFM) and differential scanning calorimeter (DSC), respectively. The dialysis method was applied to investigate the release behavior of ITZ-PM in vitro, and the release mechanism was further discussed. Drug-loading and encapsulation efficiency of ITZ-PM were 3.82% and 99.4%, respectively; nanopartiele size was 37.8 nm, and pH was 4. 48. Itraeonazole was found to be encapsulated in the micelles rather than forming a physical mixture by DSC; ITZ-PM exhibited to be almost spherical in shape from the observation by AFM. It was proved that ITZ-PM had sustained-release effect in vitro which could be described by Peppas-Sahlin equation. Results showed that mPEG-PLA can obviously improve the solubility of itraconazole.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2012年第4期302-306,共5页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.81072588) 国家"重大新药创制"科技重大专项资助项目(No.2011ZX11501)~~
关键词 伊曲康唑 聚乙二醇单甲醚-聚丙交脂嵌段共聚物 聚合物胶束 体外释放 理化性质 itraconazole mPEC-PLA polymeric micelle release in vitro physico-chemical property
  • 相关文献

参考文献3

二级参考文献39

  • 1董志超,蒋雪涛.羟丙基甲基纤维素的性质对药物亲水性骨架片溶出度的影响[J].药学学报,1994,29(12):920-924. 被引量:61
  • 2张跃庭,董岸杰,邓联东,元英进.水溶性紫杉醇两亲性共聚物纳米胶束研究[J].化学工程,2005,33(2):39-43. 被引量:13
  • 3丁平田,吴雪梅.药物制剂的新型辅料2-羟丙基-β-环糊精[J].国外医药(合成药.生化药.制剂分册),1996,17(2):107-111. 被引量:62
  • 4Jain N. Estimation of the aqueous solubility: application to organic nonelectrolytes[ J ]. J Pharm Sci, 2001,90(6): 234 - 252.
  • 5SweetanaS, Akers JM. Solubility principles and practices for parenteral drug dosage form development [ J ]. PDA J Pharm Sci Technol, 1996,50(5): 130 - 142.
  • 6Carstensen JT. Drug Stability: Principles and Practices [ M ]. Third edition. New York: Marcel Dekker Inc. 1990,213 - 215.
  • 7Ni N,Sanghvi T, Yalkowsky SH.Solubilization and preformulation of carbendazim[J]. Int J Pharm, 2002,244(2) :99 - 104.
  • 8Loftsson T, Gumundsdottir H, Sigurjonsdottir JF. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray[J].lnt J Pharm, 2001, 212(1):29-40.
  • 9Alvarez Numez FA, Yalkowsky SH. Solubilization of Diazepam [ J ].PDA J Pharm Sci Technol, 1997, 51(9):33- 35.
  • 10Millard JW, Yalkowsky SH. Solubilzation by cosolvents-establishing useful constants for the log-linear model[J]. lnt J Pharm, 2002,245(3) :153 - 166.

共引文献24

同被引文献72

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部